Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

PF-06372865 in Subjects With Photosensitive Epilepsy

Phase 2

Completed

Conditions: Reflex Epilepsy, Photosensitive

Interventions: Drug: PF-06372865
Drug: Placebo
Drug: Lorazepam

First Posted Date: 2015-09-30

Last Posted Date: 2018-03-14

Lead Sponsor: Pfizer

Target Recruit Count: 7

Registration Number: NCT02564029

Locations: 🇺🇸
Consultants in Epilepsy & Neurology, PLLC, Boise, Idaho, United States
🇺🇸
Hospital of the Univ of PA Pharmacy Service, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University Hospital EEG lab, Philadelphia, Pennsylvania, United States

and more 13 locations

A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: [14C] PF-06463922

First Posted Date: 2015-09-30

Last Posted Date: 2015-12-04

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT02564562

Locations: 🇺🇸
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Phase 2

Completed

Conditions: Clostridium Difficile Associated Disease

Interventions: Biological: Clostridium difficile Vaccine
Biological: Placebo

First Posted Date: 2015-09-25

Last Posted Date: 2021-03-08

Lead Sponsor: Pfizer

Target Recruit Count: 300

Registration Number: NCT02561195

Locations: 🇺🇸
Vince & Associates Clinical Research, Inc., Overland Park, Kansas, United States
🇺🇸
Wake Research Associates, LLC, Raleigh, North Carolina, United States
🇺🇸
Avail Clinical Research, LLC, DeLand, Florida, United States

and more 13 locations

A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin

Phase 2

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: PF-06291874
Drug: Placebo

First Posted Date: 2015-09-18

Last Posted Date: 2017-08-07

Lead Sponsor: Pfizer

Target Recruit Count: 206

Registration Number: NCT02554877

Locations: 🇺🇸
Sierra Clinical Research, Roseville, California, United States
🇺🇸
NRC Research Institute, Orange, California, United States
🇺🇸
Encompass Clinical Research, Spring Valley, California, United States

and more 34 locations

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Phase 1

Terminated

Conditions: Advanced Cancer

Interventions: Drug: Avelumab
Drug: PF-04518600
Drug: PD 0360324
Drug: Utomilumab
Drug: CMP-001

First Posted Date: 2015-09-18

Last Posted Date: 2024-07-30

Lead Sponsor: Pfizer

Target Recruit Count: 409

Registration Number: NCT02554812

Locations: 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇦🇺
The Mater Hospital, North Sydney, New South Wales, Australia
🇺🇸
Mount Sinai Comprehensive Cancer Center - Aventura, Aventura, Florida, United States

and more 80 locations

Vfend Special Investigation For Pediatric - Observational

Completed

Conditions: Pediatric Safety and Effectiveness

First Posted Date: 2015-09-18

Last Posted Date: 2021-04-14

Lead Sponsor: Pfizer

Target Recruit Count: 89

Registration Number: NCT02554656

Locations: 🇯🇵
XXXXXXX, Osaka, Japan

Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2015-09-14

Last Posted Date: 2021-02-09

Lead Sponsor: Pfizer

Target Recruit Count: 700

Registration Number: NCT02548949

Locations: 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Chungcheonbuk-do, Korea, Republic of
🇰🇷
Konkuk University Chungju Hospital / Department of Psychiatry, Chungju-si, Chungcheongbuk-do, Korea, Republic of
🇰🇷
Hallym University Dongtan Sacred Heart Hospital/Department of Neuropsychiatry, Hwaseong-si, Gyeonggi Province, Korea, Republic of

and more 19 locations

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Completed

Conditions: Chronic Myeloid Leukaemia

Interventions: Drug: Bosutinib

First Posted Date: 2015-09-10

Last Posted Date: 2023-10-03

Lead Sponsor: Pfizer

Target Recruit Count: 87

Registration Number: NCT02546375

Locations: 🇬🇧
Hammersmith Hospital, London, United Kingdom
🇬🇧
Nottingham University Hospital, Nottingham, United Kingdom
🇬🇧
Royal Liverpool Hospital, Liverpool, Merseyside, United Kingdom

A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Placebo
Drug: PF-06266047

First Posted Date: 2015-09-03

Last Posted Date: 2016-06-24

Lead Sponsor: Pfizer

Target Recruit Count: 25

Registration Number: NCT02539550

Locations: 🇧🇪
Pfizer Clinical Research Unit, Bruxelles, Belgium

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease

Completed

Conditions: Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn's Disease

Interventions: Drug: Remicade
Drug: CT-P13

First Posted Date: 2015-09-03

Last Posted Date: 2020-02-13

Lead Sponsor: Pfizer

Target Recruit Count: 2565

Registration Number: NCT02539368

Locations: 🇳🇱
Catharina Ziekenhuis, Eindhoven, Netherlands
🇩🇪
Gemeinschaftspraxis im MEDICUM, Altenholz, Germany
🇳🇱
Rijnstate, Gelderland, Netherlands

and more 136 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy